ImmunoGen
IMGN
#2217
Rank
โ‚น799.49 B
Marketcap
โ‚น2,862
Share price
0.00%
Change (1 day)
147.87%
Change (1 year)

Revenue for ImmunoGen (IMGN)

Revenue in 2023 (TTM): โ‚น23.76 Billion

According to ImmunoGen 's latest financial reports the company's current revenue (TTM ) is โ‚น26.35 Billion. In 2022 the company made a revenue of โ‚น9.00 Billion an increase over the revenue in the year 2021 that were of โ‚น5.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ImmunoGen from 1996 to 2023

Annual revenue

Year Revenue Change
2023 (TTM) โ‚น23.76 B163.97%
2022 โ‚น9.00 B73.13%
2021 โ‚น5.19 B-46.26%
2020 โ‚น9.67 B64.92%
2019 โ‚น5.86 B56.99%
2018 โ‚น3.73 B-49.3%
2017 โ‚น7.37 B
2015 โ‚น3.78 B-19.48%
2014 โ‚น4.69 B-0.09%
2013 โ‚น4.70 B565.36%
2012 โ‚น0.70 B-38.91%
2011 โ‚น1.15 B68.46%
2010 โ‚น0.68 B-21%
2009 โ‚น0.86 B-47.63%
2008 โ‚น1.65 B6.95%
2007 โ‚น1.55 B-6.72%
2006 โ‚น1.66 B15.43%
2005 โ‚น1.44 B-4.79%
2004 โ‚น1.51 B180.36%
2003 โ‚น0.53 B45.57%
2002 โ‚น0.37 B43.98%
2001 โ‚น0.25 B-27.4%
2000 โ‚น0.35 B-17.55%
1999 โ‚น0.43 B912.19%
1998 โ‚น42.52 M170.48%
1997 โ‚น15.71 M9.32%
1996 โ‚น14.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น8.444 T 31,939.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.165 T 19,499.88%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น5.753 T 21,729.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น5.445 T 20,559.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น3.296 T 12,406.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น4.355 T 16,423.91%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น4.401 T 16,600.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
โ‚น210.80 B 699.80%๐Ÿ‡บ๐Ÿ‡ธ USA